Research
Pulmonary Hypertension
Lung Cancer, Lung Cancers
Embryonic Phenotype
Myocardial Ischemia
Cardiovascular Disease, Cardiovascular Diseases
Cardiac Progenitor Cells
Lung Remodeling
Neural Stem Cells
Blood Pressure
Negative Regulators, Negative Regulator
Essential Roles, Essential Role
Business Media
Myocardial Infarction
Soluble Guanylate Cyclase
Disease Mechanisms
Mouse Models, Mouse Model
Congestive Heart Failure
Circulatory Physiology
Ko Mice
Spatial Memory
Ventricular Hypertrophy
Cardiopulmonary Disease
Radiation Resistance
Endocrine Signaling
Drug Development
Vascular Injury
Rat Model, Rat Models
List of Publications (71)
In 2016
71
Nestin Expressed by PreExisting Cardiomyocytes Recapitulated in Part an Embryonic Phenotype; Suppressive Role of p38 MAPK. MA Meus, V Hertig, L Villeneuve, JF Jasmin, A Calderone Journal of Cellular Physiology, 2016.
Found on Publication Page
In 2015
70
Inhibition of the Prostaglandin Transporter PGT Lowers Blood Pressure in Hypertensive Rats and Mice. Y Chi, JF Jasmin, Y Seki, MP Lisanti, MJ Charron, DJ Lefer, VL Schuster PloS one 10 (6), e0131735, 2015.
Found on Publication Page
69
Nestin is a marker of lung remodeling secondary to myocardial infarction and type I diabetes in the rat. A Chabot, MA Meus, P Naud, V Hertig, J Dupuis, L Villeneuve, ... Journal of cellular physiology 230 (1), 170-179, 2015.
Found on Publication Page
In 2014
68
CAPER, a novel regulator of human breast cancer progression. I Mercier, DM Gonzales, K Quann, TG Pestell, A Molchansky, F Sotgia, ... Cell Cycle 13 (8), 1256-1264, 2014.
Found on Publication Page
67
Caveolin-1 regulates the anti-atherogenic properties of macrophages. S Pavlides, JL Gutierrez-Pajares, S Katiyar, JF Jasmin, I Mercier, ... Cell and tissue research 358 (3), 821-831, 2014.
Found on Publication Page
66
Nur77 suppresses pulmonary artery smooth muscle cell proliferation through inhibition of the STAT3/Pim-1/NFAT pathway. Y Liu, J Zhang, B Yi, M Chen, J Qi, Y Yin, X Lu, JF Jasmin, J Sun American journal of respiratory cell and molecular biology 50 (2), 379-388, 2014.
Found on Publication Page
In 2013
65
Glutamine supplementation alleviates vasculopathy and corrects metabolic profile in an in vivo model of endothelial cell dysfunction. F Addabbo, Q Chen, DP Patel, M Rabadi, B Ratliff, F Zhang, JF Jasmin, ... PloS one 8 (6), e65458, 2013.
Found on Publication Page
64
Genetic ablation of caveolin-2 sensitizes mice to bleomycin-induced injury. C Almeida, JF Jasmin, F Del Galdo, MP Lisanti Cell Cycle 12 (14), 2248-2254, 2013.
Found on Publication Page
63
Cardiac resident nestin+ cells participate in reparative vascularisation. V ElHelou, A Chabot, H Gosselin, L Villeneuve, ME ClavetLanthier, ... Journal of cellular physiology 228 (9), 1844-1853, 2013.
Found on Publication Page
62
Caveolin-1 is a negative regulator of tumor growth in glioblastoma and modulates chemosensitivity to temozolomide. K Quann, DM Gonzales, I Mercier, C Wang, F Sotgia, RG Pestell, ... Cell Cycle 12 (10), 1510-1520, 2013.
Found on Publication Page
In 2012
61
Pressure-overload induced subcellular re-localization/oxidation of soluble guanylate cyclase in the heart modulates enzyme stimulation. JF Jasmin Circ Res 110 (2), 295-303, 2012.
Found on Publication Page
60
PP004-SUN GLUTAMINE SUPPLEMENTATION ALLEVIATES VASCULOPATHY AND ALTERS PLASMA METABOLOME IN AN IN VIVO MODEL OF ENDOTHELIAL CELL DYSFUNCTION. F Addabbo, Q Chen, MM Rabadi, BB Ratliff, F Zhang, A Nasjletti, ... Clinical Nutrition Supplements 7 (1), 26, 2012.
Found on Publication Page
59
Caveolins and caveolae: roles in signaling and disease mechanisms. JF Jasmin, P Frank, MP Lisanti Springer Science & Business Media, 2012.
Found on Publication Page
58
Essential role of caveolin-3 in adiponectin signalsome formation and adiponectin cardioprotection. Y Wang, X Wang, JF Jasmin, WB Lau, R Li, Y Yuan, W Yi, K Chuprun, ... Arteriosclerosis, thrombosis, and vascular biology 32 (4), 934-942, 2012.
Found on Publication Page
57
Pressure-OverloadInduced Subcellular Relocalization/Oxidation of Soluble Guanylyl Cyclase in the Heart Modulates Enzyme Stimulation. EJ Tsai, Y Liu, N Koitabashi, D Bedja, T Danner, JF Jasmin, MP Lisanti, ... Circulation research 110 (2), 295-303, 2012.
Found on Publication Page
56
Caveolin-1 and accelerated host aging in the breast tumor microenvironment: chemoprevention with rapamycin, an mTOR inhibitor and anti-aging drug. I Mercier, J Camacho, K Titchen, DM Gonzales, K Quann, KG Bryant, ... The American journal of pathology 181 (1), 278-293, 2012.
Found on Publication Page
In 2011
54
Caveolins in Cancer Pathogenesis, Prevention and Therapy. Springer Science & Business Media, 2011.
Found on Publication Page
53
Essential Role of Caveolin-3 in Adiponectin Signalsome Formation and Adiponectin Cardioprotection. Y Wang, E Gao, X Wang, JF Jasmin, WB Lau, R Li, Y Yuan, W Yi, ... Circulation 124 (21 Supplement), A8961, 2011.
Found on Publication Page
52
Sex differences in expression and subcellular localization of heart rhythm determinant proteins. NM Thomas, JF Jasmin, MP Lisanti, DA Iacobas Biochemical and biophysical research communications 406 (1), 117-122, 2011.
Found on Publication Page
51
Caveolin-1 overexpression enhances androgen-dependent growth and proliferation in the mouse prostate. KG Bryant, J Camacho, JF Jasmin, C Wang, S Addya, MC Casimiro, ... The international journal of biochemistry & cell biology 43 (9), 1318-1329, 2011.
Found on Publication Page
50
Amlodipine increases endothelial nitric oxide release by modulating binding of native eNOS protein complex to caveolin-1. A Sharma, A Trane, C Yu, JF Jasmin, P Bernatchez European journal of pharmacology 659 (2), 206-212, 2011.
Found on Publication Page
49
Development of a high-affinity inhibitor of the prostaglandin transporter. Y Chi, J Min, JF Jasmin, MP Lisanti, YT Chang, VL Schuster Journal of Pharmacology and Experimental Therapeutics 339 (2), 633-641, 2011.
Found on Publication Page
48
Caveolin-2-deficient mice show increased sensitivity to endotoxemia. CJ De Almeida, AK Witkiewicz, JF Jasmin, HB Tanowitz, F Sotgia, ... Cell cycle 10 (13), 2151-2161, 2011.
Found on Publication Page
47
Left ventricular dysfunction in murine models of heart failure and in failing human heart is associated with a selective decrease in the expression of caveolin-3. EC Feiner, P Chung, JF Jasmin, J Zhang, D Whitaker-Menezes, V Myers, ... Journal of cardiac failure 17 (3), 253-263, 2011.
Found on Publication Page
46
Caveolin-1 deficiency exacerbates cardiac dysfunction and reduces survival in mice with myocardial infarction. JF Jasmin, G Rengo, A Lymperopoulos, R Gupta, GJ Eaton, K Quann, ... American Journal of Physiology-Heart and Circulatory Physiology 300 (4 ..., 2011.
Found on Publication Page
In 2010
45
The caveolin gene family: Lessons from mouse models and human genetic disorders. MP Lisanti, I Mercier, JF Jasmin, S Pavlides, PG Frank, F Sotgia JOURNAL OF NEUROCHEMISTRY 113, 17-17, 2010.
Found on Publication Page
44
Caveolin-1 Deficiency Exacerbates Cardiac Dysfunction and Reduces Survival in Mice with Myocardial Infarction. JF Jasmin, G Rengo, A Lymperopoulos, R Gupta, GJ Eaton, K Quann, ... Circulation 122 (Suppl 21), A14567-A14567, 2010.
Found on Publication Page
43
Mesenchymal stem cells, used as bait, disclose tissue binding sites: a tool in the search for the niche?. BB Ratliff, N Singh, K Yasuda, HC Park, F Addabbo, T Ghaly, M Rajdev, ... The American journal of pathology 177 (2), 873-883, 2010.
Found on Publication Page
42
Postobstructive regeneration of kidney is derailed when surge in renal stem cells during course of unilateral ureteral obstruction is halted. HC Park, K Yasuda, B Ratliff, A Stoessel, Y Sharkovska, I Yamamoto, ... American Journal of Physiology-Renal Physiology 298 (2), F357-F364, 2010.
Found on Publication Page
In 2009
41
Over-expression of the A1-adenosine receptor alters cardiac function by inhibiting production of caveolin-3. E Cheskis, PH Chung, BR DeGeorge, EW Feldman, H Funakoshi, ... Circulation 120 (Suppl 18), S874-S874, 2009.
Found on Publication Page
40
Using Caveolin-1 epithelial immunostaining patterns to stratify human breast cancer patients and to predict the Caveolin-1 (P132L) mutation. I Mercier, KG Bryant, F Sotgia, G Bonuccelli, AK Witkiewicz, A Dasgupta, ... Cell Cycle 8 (9), 1396-1401, 2009.
Found on Publication Page
39
Genetic ablation of caveolin-1 increases neural stem cell proliferation in the subventricular zone (SVZ) of the adult mouse brain. JF Jasmin, M Yang, L Iacovitti, MP Lisanti Cell Cycle 8 (23), 3978-3983, 2009.
Found on Publication Page
38
Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesions. I Mercier, MC Casimiro, J Zhou, C Wang, C Plymire, KG Bryant, ... The American journal of pathology 174 (4), 1172-1190, 2009.
Found on Publication Page
37
Towards a new stromal-based classification system for human breast cancer prognosis and therapy. AK Witkiewicz, MC Casimiro, A Dasgupta, I Mercier, C Wang, ... Cell Cycle 8 (11), 1654-1658, 2009.
Found on Publication Page
36
Clinical and translational implications of the caveolin gene family: lessons from mouse models and human genetic disorders. I Mercier, JF Jasmin, S Pavlides, C Minetti, N Flomenberg, RG Pestell, ... Laboratory investigation 89 (6), 614-623, 2009.
Found on Publication Page
In 2008
35
Caveolin-mimetic peptide for prevention and treatment of pulmonary hypertension and right ventricular hypertrophy. MP Lisanti, JF Jasmin US Patent App. 12/228,624, 2008.
Found on Publication Page
34
Altered emotionality, spatial memory and cholinergic function in caveolin-1 knock-out mice. L Gioiosa, C Raggi, L Ricceri, JF Jasmin, PG Frank, F Capozza, ... Behavioural brain research 188 (2), 255-262, 2008.
Found on Publication Page
33
ARC (apoptosis repressor with caspase recruitment domain) is a novel marker of human colon cancer. I Mercier, M Vuolo, JF Jasmin, CM Medina, M Williams, JM Mariadason, ... Cell Cycle 7 (11), 1640-1647, 2008.
Found on Publication Page
32
Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 down-regulation and RB tumor suppressor functional inactivation: implications for the response to hormonal therapy. I Mercier, MC Casimiro, C Wang, AL Rosenberg, J Quong, A Minkeu, ... Cancer biology & therapy 7 (8), 1212-1225, 2008.
Found on Publication Page
31
Decreased expression of caveolin 1 in patients with systemic sclerosis: crucial role in the pathogenesis of tissue fibrosis. FD Galdo, F Sotgia, CJ de Almeida, JF Jasmin, M Musick, MP Lisanti, ... Arthritis & Rheumatism 58 (9), 2854-2865, 2008.
Found on Publication Page
In 2007
30
Role of Caveolins in cerebral ischemic injury. S Malhotra, JF Jasmin, MS Dhallu, I Mercier, MP Lisanti, DM Rosenbaum ANNALS OF NEUROLOGY 62, S20-S20, 2007.
Found on Publication Page
29
190 ROLE OF CAVEOLIN-1 IN THE PATHOGENESIS OF TISSUE FIBROSIS IN SYSTEMIC SCLEROSIS. F Del Galdo, C de Almeida, JF Jasmin, MP Lisanti, S Jimenez ANNALS OF THE RHEUMATIC DISEASES 66, A64-A65, 2007.
Found on Publication Page
28
Administration of a Caveolin-1 Mimetic Peptide Rescues the Cardiac and Pulmonary Abnormalities Observed in Cav-1 KO mice. JF Jasmin, I Mercier, MP Lisanti Circulation 116 (Suppl 16), II_13-II_13, 2007.
Found on Publication Page
27
Caveolin-1 deficiency increases cerebral ischemic injury. JF Jasmin, S Malhotra, MS Dhallu, I Mercier, DM Rosenbaum, MP Lisanti Circulation research 100 (5), 721-729, 2007.
Found on Publication Page
In 2006
26
Therapeutic Implications of SOCS proteins. JF Jasmin, I Mercier, F Sotgia, MP Lisanti Trends in Endocrinology & Metabolism 4 (17), 150-158, 2006.
Found on Publication Page
25
Short Term Administration of a Cell Permeable Caveolin-1 Peptide Prevents the Development of Pulmonary Hypertension and Right Ventricular Hypertrophy. JF Jasmin, I Mercier, J Dupuis, HB Tanowitz, MP Lisanti Circulation 114 (Suppl 18), II_82-II_82, 2006.
Found on Publication Page
24
Neohormone systems as exciting targets for drug development. R Ivell, R Bathgate, GN Neigh, CB Nemeroff, MG Wayne, J Jonklaas, ... Update 17 (4), 2006.
Found on Publication Page
23
Modification of the pulmonary reninangiotensin system and lung structural remodelling in congestive heart failure. F Lefebvre, A Prfontaine, A Calderone, A Caron, JF Jasmin, L Villeneuve, ... Clinical Science 111 (3), 217-224, 2006.
Found on Publication Page
22
SOCS proteins and caveolin-1 as negative regulators of endocrine signaling. JF Jasmin, I Mercier, F Sotgia, MP Lisanti Trends in Endocrinology & Metabolism 17 (4), 150-158, 2006.
Found on Publication Page
21
Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy. JF Jasmin, I Mercier, J Dupuis, HB Tanowitz, MP Lisanti Circulation 114 (9), 912-920, 2006.
Found on Publication Page
In 2005
20
Caveolin proteins in cardiopulmonary disease and lung cancers. JF Jasmin, PG Frank, MP Lisanti Advances in Molecular and Cell Biology 36, 211-233, 2005.
Found on Publication Page
19
ARC, an apoptosis suppressor limited to terminally differentiated cells, is induced in human breast cancer and confers chemo-and radiation-resistance. I Mercier, M Vuolo, R Madan, X Xue, AJ Levalley, AW Ashton, JF Jasmin, ... Cell Death & Differentiation 12 (6), 682-686, 2005.
Found on Publication Page
In 2004
17
Evaluation of luminal endothelin-converting enzyme activity in the pulmonary and coronary circulations. JF Jasmin, J Dupuis Journal of cardiovascular pharmacology 43 (1), 21-25, 2004.
Found on Publication Page
16
Lung remodeling and pulmonary hypertension after myocardial infarction: pathogenic role of reduced caveolin expression. JF Jasmin, I Mercier, R Hnasko, MWC Cheung, HB Tanowitz, J Dupuis, ... Cardiovascular research 63 (4), 747-755, 2004.
Found on Publication Page
15
Caveolin-1 deficiency stimulates neointima formation during vascular injury. GS Hassan, JF Jasmin, W Schubert, PG Frank, MP Lisanti Biochemistry 43 (26), 8312-8321, 2004.
Found on Publication Page
In 2003
14
Evaluation of the luminal endothelin-converting enzyme activity in coronary circulation. JF Jasmin, A Caron, J Dupuis FASEB JOURNAL 17 (4), A509-A509, 2003.
Found on Publication Page
13
Activation of the right ventricular endothelin (ET) system in the monocrotaline model of pulmonary hypertension: response to chronic ETA receptor blockade. JF JASMIN, P CERNACEK, J DUPUIS Clinical Science 105 (6), 647-653, 2003.
Found on Publication Page
12
Lung structural remodeling and pulmonary hypertension after myocardial infarction: complete reversal with irbesartan. JF Jasmin, A Calderone, TK Leung, L Villeneuve, J Dupuis Cardiovascular research 58 (3), 621-631, 2003.
Found on Publication Page
In 2002
11
The lung does not remove or hydrolyse Big-ET-1 during a single transit time. JF Jasmin, J Dupuis FASEB JOURNAL 16 (4), A70-A70, 2002.
Found on Publication Page
10
Beneficial effects of long-term use of the antioxidant probucol in heart failure in the rat. YT Sia, N Lapointe, TG Parker, JN Tsoporis, CF Deschepper, ... Circulation 105 (21), 2549-2555, 2002.
Found on Publication Page
In 2001
9
Beneficial effects of probucol on neurohumoral activation and cardiac cytokine expression in the postinfarction rat model. YT Sia, JF Sarrazin, JF Jasmin, A Calderone, JL Rouleau JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 37 (2), 374A-374A, 2001.
Found on Publication Page
8
Effect of ET A Receptor Antagonist on Pulmonary Hypertension and Vascular Reactivity in Rats With Congestive Heart Failure. M Lucas, JF Jasmin, J Dupuis Pulmonary pharmacology & therapeutics 14 (4), 307-314, 2001.
Found on Publication Page
7
Effectiveness of a nonselective ETA/B and a selective ETA antagonist in rats with monocrotaline-induced pulmonary hypertension. JF Jasmin, M Lucas, P Cernacek, J Dupuis Circulation 103 (2), 314-318, 2001.
Found on Publication Page
In 2000
6
Superiority of a non-selective over a selective ET~ A antagonist in monocrotaline (MCT)-induced pulmonary hypertension (PH) and right ventricular hypertrophy (RVH) in rats. JF Jasmin, J Dupuis CANADIAN JOURNAL OF CARDIOLOGY 16, 201-201, 2000.
Found on Publication Page
5
Cardioprotective effects of probucol in a rat model of myocardial infarction. YT Sia, A Calderone, JF Sarrazin, JF Jasmin, JL Rouleau CANADIAN JOURNAL OF CARDIOLOGY 16, 445-445, 2000.
Found on Publication Page
4
Superiority of mixed ETA/B over specific ETA antagonist in treatment of pulmonary hypertension and right ventricular hypertrophy in the monocrotaline rat model. JF Jasmin, J Dupuis JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 35 (2), 323A-323A, 2000.
Found on Publication Page
3
Importance of local production of endothelin-1 and of the ET B receptor in the regulation of pulmonary vascular tone. J Dupuis, JF Jasmin, S Prie, P Cernacek Pulmonary pharmacology & therapeutics 13 (3), 135-140, 2000.
Found on Publication Page
Unspecified
